Luxa Biotechnology

Fort Lee, United States

Luxa Biotechnology is a clinical-stage biotechnology firm developing a unique adult RPE stem cell (RPESC) therapy for dry AMD.

$4.0M raised

May 2024

Grant

Clinical Trials Therapeutics

Top Investors

California Institute for Regenerative Medicine

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Luxa Biotechnology

How much funding has Luxa Biotechnology raised?

Luxa Biotechnology has raised $4.0M in total funding. The most recent round was Grant. The last funding was announced in May 2024.

Who are Luxa Biotechnology's investors?

Luxa Biotechnology's investors include California Institute for Regenerative Medicine.

Where is Luxa Biotechnology headquartered?

Luxa Biotechnology is headquartered in Fort Lee, United States.

What does Luxa Biotechnology do?

Luxa Biotechnology is a clinical-stage biotechnology firm developing a unique adult RPE stem cell (RPESC) therapy for dry AMD.

What stage is Luxa Biotechnology at?

Luxa Biotechnology is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 1, 2024.

MLA

"Luxa Biotechnology — Funding & Investors." VCBacked, May 1, 2024, https://www.vcbacked.co/company/luxa-biotechnology. Accessed July 1, 2026.

APA

VCBacked. (2024). Luxa Biotechnology — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/luxa-biotechnology

Wikipedia (cite web)

{{cite web |title=Luxa Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/luxa-biotechnology |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 1, 2024.

Similar Companies in Clinical Trials